Hisamitsu Pharmaceutical Co., Inc.
Hisamitsu Pharmaceutical Co., Inc. 4530.T Peers
See (4530.T) competitors and their performances in Stock Market.
Peer Comparison Table: Drug Manufacturers - Specialty & Generic Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| 4530.T | ¥4,349.00 | +1.54% | 317.3B | 14.73 | ¥295.25 | +1.03% |
| 4502.T | ¥4,349.00 | -0.59% | 6.8T | 64.50 | ¥67.43 | +4.51% |
| 4507.T | ¥2,486.00 | +1.14% | 2.1T | 12.31 | ¥201.99 | +2.31% |
| 4523.T | ¥4,054.00 | -1.79% | 1.1T | 24.55 | ¥165.14 | +3.95% |
| 4581.T | ¥8,580.00 | -0.12% | 703.3B | 83.43 | ¥102.84 | N/A |
| 4506.T | ¥1,058.00 | +2.22% | 420.3B | 17.79 | ¥59.48 | N/A |
| 8129.T | ¥4,608.00 | +0.68% | 288.5B | 16.21 | ¥284.30 | +1.41% |
| 4540.T | ¥3,373.00 | -1.32% | 255.5B | 7.90 | ¥427.16 | +4.03% |
| 4516.T | ¥3,646.00 | -0.76% | 245.7B | 7.54 | ¥483.48 | +3.40% |
| 4887.T | ¥1,821.00 | -0.63% | 210.2B | 17.23 | ¥105.70 | +1.48% |
Stock Comparison
4530.T vs 4502.T Comparison
4530.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 4530.T stands at 317.3B. In comparison, 4502.T has a market cap of 6.8T. Regarding current trading prices, 4530.T is priced at ¥4,349.00, while 4502.T trades at ¥4,349.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
4530.T currently has a P/E ratio of 14.73, whereas 4502.T's P/E ratio is 64.50. In terms of profitability, 4530.T's ROE is +0.08%, compared to 4502.T's ROE of +0.01%. Regarding short-term risk, 4530.T is more volatile compared to 4502.T. This indicates potentially higher risk in terms of short-term price fluctuations for 4530.T.
4530.T vs 4507.T Comparison
4530.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 4530.T stands at 317.3B. In comparison, 4507.T has a market cap of 2.1T. Regarding current trading prices, 4530.T is priced at ¥4,349.00, while 4507.T trades at ¥2,486.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
4530.T currently has a P/E ratio of 14.73, whereas 4507.T's P/E ratio is 12.31. In terms of profitability, 4530.T's ROE is +0.08%, compared to 4507.T's ROE of +0.13%. Regarding short-term risk, 4530.T is more volatile compared to 4507.T. This indicates potentially higher risk in terms of short-term price fluctuations for 4530.T.
4530.T vs 4523.T Comparison
4530.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 4530.T stands at 317.3B. In comparison, 4523.T has a market cap of 1.1T. Regarding current trading prices, 4530.T is priced at ¥4,349.00, while 4523.T trades at ¥4,054.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
4530.T currently has a P/E ratio of 14.73, whereas 4523.T's P/E ratio is 24.55. In terms of profitability, 4530.T's ROE is +0.08%, compared to 4523.T's ROE of +0.05%. Regarding short-term risk, 4530.T is less volatile compared to 4523.T. This indicates potentially lower risk in terms of short-term price fluctuations for 4530.T.
4530.T vs 4581.T Comparison
4530.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 4530.T stands at 317.3B. In comparison, 4581.T has a market cap of 703.3B. Regarding current trading prices, 4530.T is priced at ¥4,349.00, while 4581.T trades at ¥8,580.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
4530.T currently has a P/E ratio of 14.73, whereas 4581.T's P/E ratio is 83.43. In terms of profitability, 4530.T's ROE is +0.08%, compared to 4581.T's ROE of +0.02%. Regarding short-term risk, 4530.T is more volatile compared to 4581.T. This indicates potentially higher risk in terms of short-term price fluctuations for 4530.T.
4530.T vs 4506.T Comparison
4530.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 4530.T stands at 317.3B. In comparison, 4506.T has a market cap of 420.3B. Regarding current trading prices, 4530.T is priced at ¥4,349.00, while 4506.T trades at ¥1,058.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
4530.T currently has a P/E ratio of 14.73, whereas 4506.T's P/E ratio is 17.79. In terms of profitability, 4530.T's ROE is +0.08%, compared to 4506.T's ROE of +0.15%. Regarding short-term risk, 4530.T is less volatile compared to 4506.T. This indicates potentially lower risk in terms of short-term price fluctuations for 4530.T.
4530.T vs 8129.T Comparison
4530.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 4530.T stands at 317.3B. In comparison, 8129.T has a market cap of 288.5B. Regarding current trading prices, 4530.T is priced at ¥4,349.00, while 8129.T trades at ¥4,608.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
4530.T currently has a P/E ratio of 14.73, whereas 8129.T's P/E ratio is 16.21. In terms of profitability, 4530.T's ROE is +0.08%, compared to 8129.T's ROE of +0.08%. Regarding short-term risk, 4530.T is less volatile compared to 8129.T. This indicates potentially lower risk in terms of short-term price fluctuations for 4530.T.
4530.T vs 4540.T Comparison
4530.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 4530.T stands at 317.3B. In comparison, 4540.T has a market cap of 255.5B. Regarding current trading prices, 4530.T is priced at ¥4,349.00, while 4540.T trades at ¥3,373.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
4530.T currently has a P/E ratio of 14.73, whereas 4540.T's P/E ratio is 7.90. In terms of profitability, 4530.T's ROE is +0.08%, compared to 4540.T's ROE of +0.11%. Regarding short-term risk, 4530.T is more volatile compared to 4540.T. This indicates potentially higher risk in terms of short-term price fluctuations for 4530.T.
4530.T vs 4516.T Comparison
4530.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 4530.T stands at 317.3B. In comparison, 4516.T has a market cap of 245.7B. Regarding current trading prices, 4530.T is priced at ¥4,349.00, while 4516.T trades at ¥3,646.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
4530.T currently has a P/E ratio of 14.73, whereas 4516.T's P/E ratio is 7.54. In terms of profitability, 4530.T's ROE is +0.08%, compared to 4516.T's ROE of +0.14%. Regarding short-term risk, 4530.T is more volatile compared to 4516.T. This indicates potentially higher risk in terms of short-term price fluctuations for 4530.T.
4530.T vs 4887.T Comparison
4530.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 4530.T stands at 317.3B. In comparison, 4887.T has a market cap of 210.2B. Regarding current trading prices, 4530.T is priced at ¥4,349.00, while 4887.T trades at ¥1,821.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
4530.T currently has a P/E ratio of 14.73, whereas 4887.T's P/E ratio is 17.23. In terms of profitability, 4530.T's ROE is +0.08%, compared to 4887.T's ROE of +0.12%. Regarding short-term risk, 4530.T is more volatile compared to 4887.T. This indicates potentially higher risk in terms of short-term price fluctuations for 4530.T.
4530.T vs 4547.T Comparison
4530.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 4530.T stands at 317.3B. In comparison, 4547.T has a market cap of 178.9B. Regarding current trading prices, 4530.T is priced at ¥4,349.00, while 4547.T trades at ¥4,180.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
4530.T currently has a P/E ratio of 14.73, whereas 4547.T's P/E ratio is 15.24. In terms of profitability, 4530.T's ROE is +0.08%, compared to 4547.T's ROE of +0.06%. Regarding short-term risk, 4530.T is less volatile compared to 4547.T. This indicates potentially lower risk in terms of short-term price fluctuations for 4530.T.
4530.T vs 4551.T Comparison
4530.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 4530.T stands at 317.3B. In comparison, 4551.T has a market cap of 178.2B. Regarding current trading prices, 4530.T is priced at ¥4,349.00, while 4551.T trades at ¥6,340.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
4530.T currently has a P/E ratio of 14.73, whereas 4551.T's P/E ratio is 32.05. In terms of profitability, 4530.T's ROE is +0.08%, compared to 4551.T's ROE of +0.05%. Regarding short-term risk, 4530.T is more volatile compared to 4551.T. This indicates potentially higher risk in terms of short-term price fluctuations for 4530.T.
4530.T vs 4553.T Comparison
4530.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 4530.T stands at 317.3B. In comparison, 4553.T has a market cap of 145.7B. Regarding current trading prices, 4530.T is priced at ¥4,349.00, while 4553.T trades at ¥2,959.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
4530.T currently has a P/E ratio of 14.73, whereas 4553.T's P/E ratio is 7.67. In terms of profitability, 4530.T's ROE is +0.08%, compared to 4553.T's ROE of +0.11%. Regarding short-term risk, 4530.T is less volatile compared to 4553.T. This indicates potentially lower risk in terms of short-term price fluctuations for 4530.T.
4530.T vs 4521.T Comparison
4530.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 4530.T stands at 317.3B. In comparison, 4521.T has a market cap of 141.1B. Regarding current trading prices, 4530.T is priced at ¥4,349.00, while 4521.T trades at ¥3,855.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
4530.T currently has a P/E ratio of 14.73, whereas 4521.T's P/E ratio is 10.55. In terms of profitability, 4530.T's ROE is +0.08%, compared to 4521.T's ROE of +0.09%. Regarding short-term risk, 4530.T is more volatile compared to 4521.T. This indicates potentially higher risk in terms of short-term price fluctuations for 4530.T.
4530.T vs 4534.T Comparison
4530.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 4530.T stands at 317.3B. In comparison, 4534.T has a market cap of 104.4B. Regarding current trading prices, 4530.T is priced at ¥4,349.00, while 4534.T trades at ¥2,945.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
4530.T currently has a P/E ratio of 14.73, whereas 4534.T's P/E ratio is 18.36. In terms of profitability, 4530.T's ROE is +0.08%, compared to 4534.T's ROE of +0.04%. Regarding short-term risk, 4530.T is more volatile compared to 4534.T. This indicates potentially higher risk in terms of short-term price fluctuations for 4530.T.
4530.T vs 4559.T Comparison
4530.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 4530.T stands at 317.3B. In comparison, 4559.T has a market cap of 89.8B. Regarding current trading prices, 4530.T is priced at ¥4,349.00, while 4559.T trades at ¥2,038.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
4530.T currently has a P/E ratio of 14.73, whereas 4559.T's P/E ratio is 9.04. In terms of profitability, 4530.T's ROE is +0.08%, compared to 4559.T's ROE of +0.12%. Regarding short-term risk, 4530.T is more volatile compared to 4559.T. This indicates potentially higher risk in terms of short-term price fluctuations for 4530.T.
4530.T vs 4569.T Comparison
4530.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 4530.T stands at 317.3B. In comparison, 4569.T has a market cap of 78.3B. Regarding current trading prices, 4530.T is priced at ¥4,349.00, while 4569.T trades at ¥1,483.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
4530.T currently has a P/E ratio of 14.73, whereas 4569.T's P/E ratio is 9.37. In terms of profitability, 4530.T's ROE is +0.08%, compared to 4569.T's ROE of +0.07%. Regarding short-term risk, 4530.T is more volatile compared to 4569.T. This indicates potentially higher risk in terms of short-term price fluctuations for 4530.T.
4530.T vs 4886.T Comparison
4530.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 4530.T stands at 317.3B. In comparison, 4886.T has a market cap of 66.2B. Regarding current trading prices, 4530.T is priced at ¥4,349.00, while 4886.T trades at ¥2,335.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
4530.T currently has a P/E ratio of 14.73, whereas 4886.T's P/E ratio is 12.98. In terms of profitability, 4530.T's ROE is +0.08%, compared to 4886.T's ROE of +0.08%. Regarding short-term risk, 4530.T is more volatile compared to 4886.T. This indicates potentially higher risk in terms of short-term price fluctuations for 4530.T.
4530.T vs 4554.T Comparison
4530.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 4530.T stands at 317.3B. In comparison, 4554.T has a market cap of 32.3B. Regarding current trading prices, 4530.T is priced at ¥4,349.00, while 4554.T trades at ¥1,323.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
4530.T currently has a P/E ratio of 14.73, whereas 4554.T's P/E ratio is 10.13. In terms of profitability, 4530.T's ROE is +0.08%, compared to 4554.T's ROE of +0.07%. Regarding short-term risk, 4530.T is more volatile compared to 4554.T. This indicates potentially higher risk in terms of short-term price fluctuations for 4530.T.
4530.T vs 4577.T Comparison
4530.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 4530.T stands at 317.3B. In comparison, 4577.T has a market cap of 31.6B. Regarding current trading prices, 4530.T is priced at ¥4,349.00, while 4577.T trades at ¥1,043.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
4530.T currently has a P/E ratio of 14.73, whereas 4577.T's P/E ratio is 14.76. In terms of profitability, 4530.T's ROE is +0.08%, compared to 4577.T's ROE of +0.04%. Regarding short-term risk, 4530.T is less volatile compared to 4577.T. This indicates potentially lower risk in terms of short-term price fluctuations for 4530.T.
4530.T vs 9273.T Comparison
4530.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 4530.T stands at 317.3B. In comparison, 9273.T has a market cap of 29.4B. Regarding current trading prices, 4530.T is priced at ¥4,349.00, while 9273.T trades at ¥697.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
4530.T currently has a P/E ratio of 14.73, whereas 9273.T's P/E ratio is 8.36. In terms of profitability, 4530.T's ROE is +0.08%, compared to 9273.T's ROE of +0.14%. Regarding short-term risk, 4530.T is more volatile compared to 9273.T. This indicates potentially higher risk in terms of short-term price fluctuations for 4530.T.
4530.T vs 4595.T Comparison
4530.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 4530.T stands at 317.3B. In comparison, 4595.T has a market cap of 29.1B. Regarding current trading prices, 4530.T is priced at ¥4,349.00, while 4595.T trades at ¥1,528.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
4530.T currently has a P/E ratio of 14.73, whereas 4595.T's P/E ratio is 7.71. In terms of profitability, 4530.T's ROE is +0.08%, compared to 4595.T's ROE of +0.22%. Regarding short-term risk, 4530.T is more volatile compared to 4595.T. This indicates potentially higher risk in terms of short-term price fluctuations for 4530.T.
4530.T vs 2929.T Comparison
4530.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 4530.T stands at 317.3B. In comparison, 2929.T has a market cap of 26.3B. Regarding current trading prices, 4530.T is priced at ¥4,349.00, while 2929.T trades at ¥906.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
4530.T currently has a P/E ratio of 14.73, whereas 2929.T's P/E ratio is 9.62. In terms of profitability, 4530.T's ROE is +0.08%, compared to 2929.T's ROE of +0.24%. Regarding short-term risk, 4530.T is more volatile compared to 2929.T. This indicates potentially higher risk in terms of short-term price fluctuations for 4530.T.
4530.T vs 4538.T Comparison
4530.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 4530.T stands at 317.3B. In comparison, 4538.T has a market cap of 18.2B. Regarding current trading prices, 4530.T is priced at ¥4,349.00, while 4538.T trades at ¥2,128.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
4530.T currently has a P/E ratio of 14.73, whereas 4538.T's P/E ratio is 8.26. In terms of profitability, 4530.T's ROE is +0.08%, compared to 4538.T's ROE of +0.07%. Regarding short-term risk, 4530.T is more volatile compared to 4538.T. This indicates potentially higher risk in terms of short-term price fluctuations for 4530.T.
4530.T vs 4574.T Comparison
4530.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 4530.T stands at 317.3B. In comparison, 4574.T has a market cap of 12.2B. Regarding current trading prices, 4530.T is priced at ¥4,349.00, while 4574.T trades at ¥243.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
4530.T currently has a P/E ratio of 14.73, whereas 4574.T's P/E ratio is -4.89. In terms of profitability, 4530.T's ROE is +0.08%, compared to 4574.T's ROE of +0.11%. Regarding short-term risk, 4530.T is less volatile compared to 4574.T. This indicates potentially lower risk in terms of short-term price fluctuations for 4530.T.
4530.T vs 4512.T Comparison
4530.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 4530.T stands at 317.3B. In comparison, 4512.T has a market cap of 10.4B. Regarding current trading prices, 4530.T is priced at ¥4,349.00, while 4512.T trades at ¥301.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
4530.T currently has a P/E ratio of 14.73, whereas 4512.T's P/E ratio is 54.93. In terms of profitability, 4530.T's ROE is +0.08%, compared to 4512.T's ROE of +0.01%. Regarding short-term risk, 4530.T is less volatile compared to 4512.T. This indicates potentially lower risk in terms of short-term price fluctuations for 4530.T.
4530.T vs 4524.T Comparison
4530.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 4530.T stands at 317.3B. In comparison, 4524.T has a market cap of 8.7B. Regarding current trading prices, 4530.T is priced at ¥4,349.00, while 4524.T trades at ¥2,119.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
4530.T currently has a P/E ratio of 14.73, whereas 4524.T's P/E ratio is 21.31. In terms of profitability, 4530.T's ROE is +0.08%, compared to 4524.T's ROE of +0.04%. Regarding short-term risk, 4530.T is more volatile compared to 4524.T. This indicates potentially higher risk in terms of short-term price fluctuations for 4530.T.
4530.T vs 4582.T Comparison
4530.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 4530.T stands at 317.3B. In comparison, 4582.T has a market cap of 8.3B. Regarding current trading prices, 4530.T is priced at ¥4,349.00, while 4582.T trades at ¥170.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
4530.T currently has a P/E ratio of 14.73, whereas 4582.T's P/E ratio is -1.84. In terms of profitability, 4530.T's ROE is +0.08%, compared to 4582.T's ROE of -0.91%. Regarding short-term risk, 4530.T is less volatile compared to 4582.T. This indicates potentially lower risk in terms of short-term price fluctuations for 4530.T.
4530.T vs 4892.T Comparison
4530.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 4530.T stands at 317.3B. In comparison, 4892.T has a market cap of 7.6B. Regarding current trading prices, 4530.T is priced at ¥4,349.00, while 4892.T trades at ¥919.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
4530.T currently has a P/E ratio of 14.73, whereas 4892.T's P/E ratio is -8.48. In terms of profitability, 4530.T's ROE is +0.08%, compared to 4892.T's ROE of -0.31%. Regarding short-term risk, 4530.T is less volatile compared to 4892.T. This indicates potentially lower risk in terms of short-term price fluctuations for 4530.T.
4530.T vs 7079.T Comparison
4530.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 4530.T stands at 317.3B. In comparison, 7079.T has a market cap of 7.2B. Regarding current trading prices, 4530.T is priced at ¥4,349.00, while 7079.T trades at ¥3,010.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
4530.T currently has a P/E ratio of 14.73, whereas 7079.T's P/E ratio is 7.64. In terms of profitability, 4530.T's ROE is +0.08%, compared to 7079.T's ROE of +0.23%. Regarding short-term risk, 4530.T is more volatile compared to 7079.T. This indicates potentially higher risk in terms of short-term price fluctuations for 4530.T.
4530.T vs 4883.T Comparison
4530.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 4530.T stands at 317.3B. In comparison, 4883.T has a market cap of 6.8B. Regarding current trading prices, 4530.T is priced at ¥4,349.00, while 4883.T trades at ¥88.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
4530.T currently has a P/E ratio of 14.73, whereas 4883.T's P/E ratio is -3.08. In terms of profitability, 4530.T's ROE is +0.08%, compared to 4883.T's ROE of -0.58%. Regarding short-term risk, 4530.T is less volatile compared to 4883.T. This indicates potentially lower risk in terms of short-term price fluctuations for 4530.T.
4530.T vs 4597.T Comparison
4530.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 4530.T stands at 317.3B. In comparison, 4597.T has a market cap of 6.7B. Regarding current trading prices, 4530.T is priced at ¥4,349.00, while 4597.T trades at ¥30.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
4530.T currently has a P/E ratio of 14.73, whereas 4597.T's P/E ratio is -3.07. In terms of profitability, 4530.T's ROE is +0.08%, compared to 4597.T's ROE of -1.24%. Regarding short-term risk, 4530.T is less volatile compared to 4597.T. This indicates potentially lower risk in terms of short-term price fluctuations for 4530.T.
4530.T vs 4539.T Comparison
4530.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 4530.T stands at 317.3B. In comparison, 4539.T has a market cap of 5.3B. Regarding current trading prices, 4530.T is priced at ¥4,349.00, while 4539.T trades at ¥1,476.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
4530.T currently has a P/E ratio of 14.73, whereas 4539.T's P/E ratio is -20.73. In terms of profitability, 4530.T's ROE is +0.08%, compared to 4539.T's ROE of +0.02%. Regarding short-term risk, 4530.T is more volatile compared to 4539.T. This indicates potentially higher risk in terms of short-term price fluctuations for 4530.T.
4530.T vs 4586.T Comparison
4530.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 4530.T stands at 317.3B. In comparison, 4586.T has a market cap of 3B. Regarding current trading prices, 4530.T is priced at ¥4,349.00, while 4586.T trades at ¥61.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
4530.T currently has a P/E ratio of 14.73, whereas 4586.T's P/E ratio is -4.57. In terms of profitability, 4530.T's ROE is +0.08%, compared to 4586.T's ROE of -0.49%. Regarding short-term risk, 4530.T is less volatile compared to 4586.T. This indicates potentially lower risk in terms of short-term price fluctuations for 4530.T.
4530.T vs 4541.T Comparison
4530.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 4530.T stands at 317.3B. In comparison, 4541.T has a market cap of 2.5B. Regarding current trading prices, 4530.T is priced at ¥4,349.00, while 4541.T trades at ¥35.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
4530.T currently has a P/E ratio of 14.73, whereas 4541.T's P/E ratio is -0.00. In terms of profitability, 4530.T's ROE is +0.08%, compared to 4541.T's ROE of +0.13%. Regarding short-term risk, 4530.T is less volatile compared to 4541.T. This indicates potentially lower risk in terms of short-term price fluctuations for 4530.T.